767342-46-1Relevant articles and documents
Nitrogen bicyclic compounds as inhibitors for Scyl1 and Grk5
-
Paragraph 0183; 0184, (2015/01/18)
The present invention relates to compounds assumed to be capable of modulating the activity of the proteins ScyI1 and Grk5, thereby regulating the expression and/or release of insulin as well as to pharmaceutical compositions containing such compounds and the use thereof especially for the treatment of a metabolic disease such as diabetes, obesity and impaired adipogenesis.